PATTERNS OF ADJUVANT TREATMENT FOR ENDOMETRIAL CANCER : THE EXPERIENCE OF A SINGLE INSTITUTION IN MOROCCO

Endometrial cancer is the fourth most common malignant tumor in women developed countries, and Morocco it represents third gynecological cancer. It primarily affects postmenopausal women. Our study a retrospective descriptive conducted from 01/01/2014 to 01/01/2018 at radiation therapy department of National Institute Oncology Rabat. Data were collected medical records included epidemiological, clinical, therapeutic prognostic aspects this The median age diagnosis was 61 years. delay consultation 6 months. histological made by endometrial biopsy 52.3% cases. Pathological examination revealed endometrioid adenocarcinoma 91% 32 patients received adjuvant treatment consisting external radiotherapy dose 46 Gy 23 fractions, followed vaginal brachytherapy (37%), which these also sequential chemotherapy (7.1%). 21 treated with alone (25%), 11 (13%), concurrent radiochemotherapy (25%). interval between surgery 42 days. In our series, overall 5-year survival rate 93.6% for all stages combined.